Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Lyra Therapeutics, Inc. (LYRA) had Current Liabilities of $9.48M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.03M |
|
$-5.98M |
|
-- |
|
$0.03M |
|
$6.26M |
|
$-6.24M |
|
$0.26M |
|
$-5.98M |
|
$-5.98M |
|
$-5.98M |
|
$-5.98M |
|
$-5.98M |
|
$-5.98M |
|
$-6.24M |
|
$-6.13M |
|
1.77M |
|
1.77M |
|
$-3.38 |
|
$-3.38 |
|
| Balance Sheet Financials | |
$23.02M |
|
$1.12M |
|
$20.69M |
|
$43.71M |
|
|
Current Liabilities |
$9.48M |
-- |
|
$38.56M |
|
$48.04M |
|
$-4.33M |
|
$-4.33M |
|
$-4.33M |
|
1.64M |
|
| Cash Flow Statement Financials | |
$-22.79M |
|
$-0.00M |
|
$4.27M |
|
$42.57M |
|
$24.05M |
|
$-18.52M |
|
$1.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.43 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-24948.00% |
|
-24948.00% |
|
-- |
|
-23924.00% |
|
-23936.00% |
|
$-22.80M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
138.12% |
|
138.12% |
|
-13.68% |
|
138.12% |
|
$-2.63 |
|
$-12.89 |
|
$-12.89 |
|